Capital Increase / Dilution2026-05-11
ImmuneOncia Therapeutics Inc. Paid-in Capital Increase
이뮨온
이뮨온시아
424870
Signal Score
58C — Neutral
Score58 / 100
Historical Avg Return (5d)
+1.29%
Data Coverage
100%n=2029
Risk-adjusted indicator based on 2029 historical DART filings. For informational purposes only — not investment advice.
Financial Impact
NEUTRAL
Key Numbers
- • Total Shares to be Issued: 16,830,200 Shares
- • Issuance Price: 4,860 KRW/Share
3 more figures — unlock with API access
AI Analysis Summary
Developer & Pro plans
Risk Factors
Developer & Pro plans
Access Full Korean Market Signal Analytics
✔ AI-parsed DART filing classification & scoring
✔ Real-time event impact indicators
✔ Historical pattern data via REST API
This content is for informational purposes only and does not constitute investment advice. Past signal patterns do not guarantee future results. All data is sourced from public DART filings.
AI-processed analysis. Based on: [발행조건확정]증권신고서(지분증권). Source: Financial Supervisory Service (금융감독원 전자공시시스템). Raw government data is not redistributed. Not investment advice.